NCT02782949 2025-09-15
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
10 trialsNCT02944578 2024-10-29
Topical Curcumin for Precancer Cervical Lesions
Emory University
Phase 2 Terminated
NCT02100423 2024-04-12
Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Case Comprehensive Cancer Center
Phase 2 Completed
NCT00927485 2020-12-16
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
University of Puerto Rico
Phase NA Completed
NCT01740323 2019-09-18
Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy
Emory University
Phase 2 Completed
NCT02300727 2019-05-31
Study to See How Safe Curcumin is and How Well it Works When Used to Treat Mucositis in Patients Getting Chemotherapy
Aurora BayCare Medical Center
Phase 1/2 Terminated
NCT02556632 2017-11-06
Curcumin-II
University of Rochester
Phase 2 Completed
NCT01246973 2016-03-07
Oral Curcumin for Radiation Dermatitis
University of Rochester
Phase 2/3 Completed
NCT01042938 2012-06-25
Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients
University of Rochester
Phase 2 Completed
NCT00113841 2011-11-23
Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma
M.D. Anderson Cancer Center
Phase NA Completed